BIOLASE Inc (NASDAQ:BIOL)
| 1.15 BATS BZX Real-Time Price As of 3:32pm ET |  +0.02 / +1.77%Today’s Change | 1.07 Today|||52-Week Range 76.00 | -98.23% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $2.6M |
Company Description
BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems use a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1987 and is headquartered in Lake Forest, CA.
Contact Information
BIOLASE, Inc. 27042 Towne Centre Drive Lake Forest California 92610-2810 |
Employees
Shareholders
| Other institutional | 9.64% |
| Individual stakeholders | 13.84% |
| Mutual fund holders | 0.64% |
Top Executives
| John R. Beaver | President, Chief Executive Officer & Director |
| Steven Sandor | Chief Operating Officer |
| Jennifer Brighton | Chief Financial Officer |
| Russell Morrow | Chief Dental Officer |
| William E. Brown | Vice President-Innovation & Business Development |
